接种新冠病毒灭活疫苗对老年人群血压的影响及不良反应

Effect of COVID-19 inactivated vaccine on blood pressure and side effect in the elderly population

  • 摘要: 目的 观察老年人群接种新冠病毒灭活疫苗前后血压的变化及不良反应的发生情况。方法 回顾性选取60岁及以上老年人651名,首剂接种前进行全面评估(如心血管病史、血压等),排除有接种禁忌证者,筛选合格者接种两剂(每剂0.5 ml,间隔21 d)新冠病毒灭活疫苗。通过于每剂接种前、每剂接种后30 min分别测量血压,观察血压变化情况。同时,对接种后不良反应进行被动随访,利用统计学分析接种新冠病毒灭活疫苗对老年人群血压的影响,并评价不良反应的发生情况。结果 60岁及以上老年人群接种新冠病毒灭活疫苗第一剂和第二剂前后均未见血压明显改变,接种前轻度高血压患者在接种后亦未见血压明显升高。接种后未报告严重不良反应,仅收集到轻微不良反应4例。结论 接种新冠病毒灭活疫苗对老年人群血压无显著影响。老年人群中接种疫苗不良反应发生率较低,在充分评估健康状况的前提下,可全面有序地推进身体状况稳定的60岁及以上老年人群的新冠疫苗接种工作。

     

    Abstract: OBJECTIVE To observe the variation in blood pressure and the occurrence of adverse reactions in the elderly people before and after inoculation of the COVID-19 inactivated vaccine. METHODS Total of 651 participants aged less than 60-years were retrospectively analyzed. They were under a comprehensive assessment(such as medical history, allergic history) before the first dose of vaccination, and those with vaccination contraindications were excluded. Qualified candidates were selected to receive two doses(0.5 ml each, interval 21 days) of the COVID-19 inactivated vaccine. Blood pressure was measured before inoculation and 30 minutes later to observe the changes of blood pressure. Vaccine-related side effects were followed up, and the effect of inactivated the COVID-19 vaccination on blood pressure in the elderly population was analyzed. RESULTS The COVID-19 inactivated vaccine showed no significant effects on blood pressure after inoculation in the people over 60 years old. Significant hypotension and hypertension have not be observed in people with hypertension history after inoculation, and no severe adverse reactions were reported after inoculation, only 4 cases of minor adverse reactions were collected. CONCLUSION Inoculation of the COVID-19 inactivated vaccine has no significant effect on blood pressure in the elders. Furthermore, the incidence of adverse reactions to the vaccination is low in the elderly people, supporting the comprehensive promotion of population over 60 years old with steady health conditions receiving the inoculation.

     

/

返回文章
返回